Inventor · disambiguated record
Patrick J. Muraca
Also filed as: MURACA PATRICK · MURACA PATRICK J
23 granted patents·26 pending applications·359 citations·filing 1997–2016
95Inventor score
Files withNUCLEA BIOTECHNOLOGIES INC19MURACA PATRICK J12NUCLEA BIOMARKERS LLC7CLINOMICS BIOSCIENCES INC4ALBANY MEDICAL COLLEGE1
Top patents by PatentIndex Score
49 records- 0197US8685891B2Method and assay for determining FAS expressionMURACA PATRICK J·Filed 2010·Granted Apr 1, 2014·34 cites·5 claims
- 0295US7354725B2Kinase peptides and antibodiesNUCLEA BIOMARKERS LLC·Filed 2006·Granted Apr 8, 2008·45 cites·4 claims
- 0391US8278034B2Methods of making frozen tissue microarraysMURACA PATRICK J·Filed 2001·Granted Oct 2, 2012·51 cites·13 claims
- 0487USD530021SAntibody protein analysis chipNUCLEA BIOMARKERS LLC·Filed 2005·Granted Oct 10, 2006·39 cites·1 claims
- 0587US5994071AAssessment of prostate cancerALBANY MEDICAL COLLEGE·Filed 1997·Granted Nov 30, 1999·120 cites·9 claims
- 0686US6534307B1Frozen tissue microarrayerCLINOMICS BIOSCIENCES INC·Filed 2001·Granted Mar 18, 2003·26 cites·28 claims
- 0783US8900820B2Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitorsMURACA PATRICK J·Filed 2011·Granted Dec 2, 2014·3 cites·14 claims
- 0877US6582967B2Method of forming a microarray from frozen tissueCLINOMICS BIOSCIENCES INC·Filed 2001·Granted Jun 24, 2003·13 cites·24 claims
- 0976US8129125B2Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitorsMURACA PATRICK J·Filed 2008·Granted Mar 6, 2012·3 cites·4 claims
- 1076US8088589B2Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitorsMURACA PATRICK J·Filed 2009·Granted Jan 3, 2012·3 cites·1 claims
- 1167US9029512B2Anti-phospho-Akt antibodiesMURACA PATRICK J·Filed 2009·Granted May 12, 2015·0 cites·5 claims
- 1267US2008076134A1Gene and protein expression profiles associated with the therapeutic efficacy of irinotecanNUCLEA BIOMARKERS LLC·Filed 2007·Application pending·0 cites
- 1364US6716619B1Stylet for use with tissue microarrayer and moldsCLINOMICS BIOSCIENCES INC·Filed 2001·Granted Apr 6, 2004·5 cites·21 claims
- 1462US8580926B2Gene and protein expression profiles associated with the therapeutic efficacy of irinotecanMURACA PATRICK J·Filed 2009·Granted Nov 12, 2013·0 cites·13 claims
- 1560US9732158B2Antibodies against fatty acid synthaseNUCLEA BIOTECHNOLOGIES INC·Filed 2014·Granted Aug 15, 2017·0 cites·10 claims
- 1660US9056919B2USP2a peptides and antibodiesNUCLEA BIOTECHNOLOGIES INC·Filed 2012·Granted Jun 16, 2015·0 cites·5 claims
- 1760US2013303744A1Usp2a peptides and antibodiesNUCLEA BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 1860US2013237691A1Usp2a peptides and antibodiesNUCLEA BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 1960US2015218290A1Usp2a peptides and antibodiesNUCLEA BIOTECHNOLOGIES INC·Filed 2015·Application pending·0 cites
- 2060US2013237449A1Usp2a peptides and antibodiesNUCLEA BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 2159US7763438B2Gene and protein expression profiles associated with the therapeutic efficacy of irinotecanNUCLEA BIOMARKERS LLC·Filed 2008·Granted Jul 27, 2010·0 cites·4 claims
- 2259USD473648SStyletCLINOMICS BIOSCIENCES INC·Filed 2000·Granted Apr 22, 2003·11 cites·1 claims
- 2359US2015050665A1Predictive biomarkers for breast cancerNUCLEA BIOTECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 2458US2008206777A1Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitorsNUCLEA BIOMARKERS LLC·Filed 2008·Application pending·0 cites
- 2557US9739781B2Anti-phospho-Akt antibodiesNUCLEA BIOTECHNOLOGIES INC·Filed 2015·Granted Aug 22, 2017·0 cites·7 claims
- 2657US2014127714A1Method and assay for determining fas expressionNUCLEA BIOTECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 2756US7897354B2Kinase peptides and antibodiesNUCLEA BIOTECHNOLOGIES INC·Filed 2008·Granted Mar 1, 2011·0 cites·2 claims
- 2856US2003032069A1Evaluating neuropshychiatric diseases using a specimen-linked databaseFiled 2002·Application pending·0 cites
- 2956US2003027223A1Specimen-linked G protein coupled receptor databaseFiled 2002·Application pending·0 cites
- 3054US8729239B2Antibodies against fatty acid synthaseMURACA PATRICK J·Filed 2010·Granted May 20, 2014·0 cites·6 claims
- 3154US2013095483A1Predictive biomarkers for breast cancerNUCLEA BIOTECHNOLOGIES INC·Filed 2012·Application pending·0 cites
- 3251US2011059464A1Biomarker Panel For Prediction Of Recurrent Colorectal CancerMURACA PATRICK J·Filed 2009·Application pending·0 cites
- 3351US2013338027A1Predictive Markers For Cancer and Metabolic SyndromeNUCLEA BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 3449US2014364334A1Congestive heart failure biomarkersNUCLEA BIOTECHNOLOGIES INC·Filed 2012·Application pending·0 cites
- 3546US2014371087A1Mixed format microarraysNUCLEA BIOTECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 3645US2006263826A1Antibody protein analysis chipNUCLEA BIOMARKERS LLC·Filed 2006·Application pending·0 cites
- 3744US2014127708A1Predictive biomarkers for prostate cancerMURACA PATRICK J·Filed 2012·Application pending·0 cites
- 3844US2016209412A1Msia-srm assay for biomarker analysisNUCLEA BIOTECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 3944US2014080737A1Gene expression profile for therapeutic response to vegf inhibitorsMURACA PATRICK J·Filed 2012·Application pending·0 cites
- 4043US2012149594A1Biomarkers for prediction of breast cancerMURACA PATRICK J·Filed 2011·Application pending·0 cites
- 4142US2003049701A1Oncology tissue microarraysFiled 2001·Application pending·0 cites
- 4241USD598548SStyletNUCLEA BIOMARKERS LLC·Filed 2007·Granted Aug 18, 2009·4 cites·1 claims
- 4341US2002168639A1Profile array substratesFiled 2001·Application pending·0 cites
- 4441US2002150966A1Specimen-linked databaseFiled 2001·Application pending·0 cites
- 4540US2015133342A1Mrm-ms signature assayNUCLEA BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 4638US2017146530A1Device, method and system for antigen detectionNANOMOLECULARDX LLC·Filed 2016·Application pending·0 cites
- 4737US2015309034A1Biomarker panel for prediction of recurrent colon cancerNUCLEA BIOTECHNOLOGIES INC·Filed 2015·Application pending·0 cites
- 4832USD718800SLens mountNUCLEA BIOTECHNOLOGIES INC·Filed 2012·Granted Dec 2, 2014·1 cites·1 claims
- 4931USD714959SBeam dump assemblyNUCLEA BIOTECHNOLOGIES INC·Filed 2012·Granted Oct 7, 2014·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Patrick J. Muraca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →